Risedronate and Pamidronate Treatment in the Clinical Management of Patients with Severe Paget’s Disease of Bone and Acquired Resistance to Bisphosphonates

Author： Rendina D.  

Publisher： Springer Publishing Company

ISSN： 0171-967X

Source： Calcified Tissue International, Vol.75, Iss.3, 2004-09, pp. : 189-196

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Determinants of Quality of Life in Paget’s Disease of Bone

By Langston A.   Campbell M.   Fraser W.   MacLennan G.   Selby P.   Ralston S.  

Calcified Tissue International, Vol. 80, Iss. 1, 2007-01 ,pp. : 1-9

Springer Publishing Company

Access to resources Recommend Favorite

SQSTM1 and Paget’s Disease of Bone

By Layfield R.  

Calcified Tissue International, Vol. 75, Iss. 5, 2004-11 ,pp. : 347-357

Springer Publishing Company

Access to resources Recommend Favorite

Paget’s disease of the hip: surgical management

By Parvizi Javad   Restrepo Camilo   Sim Franklin H  

Future Rheumatology, Vol. 1, Iss. 3, 2006-06 ,pp. : 373-377

Future Medicine

Access to resources Recommend Favorite

Prolonged anti-resorptive activity of zoledronic acid: evidence from postmenopausal osteopenic women and patients with Paget’s disease of bone

By Polyzos Stergios  

Clinical Rheumatology, Vol. 30, Iss. 1, 2011-01 ,pp. : 149-150

Springer Publishing Company

Access to resources Recommend Favorite

Paget’s Disease of Bone in New Zealand: Continued Decline in Disease Severity

By Cundy H.  

Calcified Tissue International, Vol. 75, Iss. 5, 2004-11 ,pp. : 358-364

Springer Publishing Company

Access to resources Recommend Favorite